Monrovia — The G-2 Pharmacy has objected to the Liberia Medicines and Well being Merchandise Regulatory Board purported decision and indefinite suspension making rounds within the native dailies
In a communication to the Chairman Dr. David Sumo, G-2 Pharmacy by way of her authorized representatives stated, the decision is each legally and procedurally inconsistent with the official Investigative Findings and Ruling dated sixteenth Might 2025, issued by the LMHRA Listening to Board.
“That ruling concluded with the imposition of a financial high quality, which G2 Pharmacy paid in full, thus resolving the matter as per LMHRA’s personal due course of. The next issuance of a decision imposing extra sanctions, with out additional investigation or listening to, constitutes administrative overreach and violates ideas of equity and finality.” The communication added.
G-2 avers that, LMHRA Act, Half IV, Part 2.1 and 5, paragraph 3(c) grants authority to difficulty or droop license expressly within the Managing Director of LMHRA.
Including that how come the Board Chair and a few members of the Board suspended G2 Pharmacy’s license? “Is it procedural? We reply an emphatic no and keep that you just acted with none authority pursuant to the LMHRA Act quoted supra.”
The communication famous that the decision alleges G2 Pharmacy imported “Bupivacaine 0.5%” with non-English labeling, and claims with out citing any factual or scientific foundation that this mislabeling triggered a fatality. This assertion just isn’t supported by identification of the alleged fatality; any medical or forensic proof of causation; documentation linking the product to a particular incident and post-mortem or toxicology check performed.
“Such obscure and unsubstantiated accusations danger damaging the popularity and standing of G2 Pharmacy and undermine the credibility of LMHRA as a regulatory authority tasked with making use of evidence-based oversight. Regulatory actions have to be based on demonstrable details and observe prescribed authorized procedures not on hypothesis or media broadcasts.”
G-2 within the communication demand the next fast actions, withdrawal of the purported decision within the absence of documented, scientific, and legally vetted proof, Public clarification by LMHRA to rectify reputational hurt brought on by the decision’s dissemination in social {and professional} boards.
Apparently, as oppose to the knowledge circulating about G-2 Pharmacy drugs is accountable for the loss of life of Isaiah Williams. On January 17, 2025, The Liberia Medical and Dental Council (LMDC) concluded an intensive investigation into the premature loss of life of Isaiah Williams, figuring out that Catholic Hospital bears vital duty on account of medical negligence and procedural failures by attending medical personnel.
Following thorough evaluate, the LMDC recognized a number of lapses in affected person care. In consequence, disciplinary measures was handed right down to quite a few hospital workers together with medical doctors and nurses starting from momentary suspensions to everlasting license revocations.
Liberia Medicines and Well being Merchandise Regulatory Board to droop G-2 Pharmacy’s license holds no authorized benefit. Underneath current regulation, the Board doesn’t possess the authority to droop pharmacy licenses.
Moreover, it was revealed that the suspension letter circulating doesn’t have the letter head of LMHRA and solely six signatures out of 11 designated board members, rendering the motion procedurally invalid.
LMHRA Clarifies Counterfeit Drug Allegations Following Teen’s Loss of life
In the meantime, the assertion comes because the Liberia Medicines and Well being Merchandise Regulatory Authority (LMHRA) has issued a clarification relating to studies of alleged counterfeit medicine.
“Whereas it’s not normal observe of the LMHRA to litigate delicate well being points within the media, it’s expedient on this occasion to lend some readability on this matter,” the company stated in a press release.
In line with the LMHRA, following the loss of life of a 16-year-old boy on the St. Joseph’s Catholic Hospital in January 2025 and the next launch of an investigative report by the Liberia Medical and Dental Council (LMDC), it launched an impartial investigation into the medical merchandise used in the course of the process. The purpose was to find out the reason for the Hostile Drug Response (ADR), assess the regulatory standing of the medication concerned, and suggest preventive measures.
The LMHRA’s findings revealed that the affected person had been administered six drugs, together with an anesthesia drug—Bupivacaine Spinal Injection (Tradename: Marcaine®️ Spinal Heavy 0.5%). The company famous that whereas ADRs usually are not unusual in medical observe, attributing the response to a particular drug is inconclusive, significantly when a number of drugs are administered.
Importantly, all drugs administered in the course of the process have been discovered to satisfy LMHRA’s fundamental regulatory necessities—apart from the Bupivacaine Spinal Injection.
The company stated the violation associated to labeling, which was executed in a overseas language, contravening Chapter 2, Part 1, Quantity 3 of LMHRA’s laws on labeling. The regulation states: “All data contained on the label of medicines and well being merchandise have to be in English.”
In line with the LMHRA, G2 Pharmacy utilized in 2022 to register the Bupivacaine Spinal Injection. Following a profitable file evaluate, the drug was registered for a three-year interval, and G2 Pharmacy has been importing it into the nation since.
The Board of Administrators of LMHRA, Dr. David Sumo, when contacted stated the Board is reviewing the G2-Pharmacy communications and launch, and can reply at an applicable time.
